Mitchell B. Trotter
Thank you, Dante. Hello, I'm Mitch Trotter, the CFO, and thank you all for attending. So a little bit of the look back, I'll give you insight into the second quarter results. And the main takeaways in Q2 are efforts to improve the balance sheet continues revenues remain level as hedging mitigated the temporary dip in production that Dante mentioned, and cost reductions in LOE and G&A and interest continue even further than where we dropped off in Q1, which is good. On the cost reduction side, G&A cost reductions will be discussed in a later slide. The LOE, as I mentioned, it dropped to $665,000 per month in Q2. This is down from last year's $718,000 per month average across 2024. Interest expense dropped another $65,000 for the quarter due to the note conversions in our efforts to clean up the balance sheet. This is $230,000 per quarter drop from where we were Q4 of 2024. So with that, I want to go to the revenue slide, please. The production, as I noted, was a temporary dip, and Jesse will discuss all those items. They want to note that the average price of oil dropped from $70 to $61 per barrel. Well, the hedging mitigated this drop, and we have collected or collected during the quarter, $290,000 in cash. The noncash hedging pickup was $600,000, which was due to the drop in oil price, but that kept the overall revenues flat. With that, let's go to the G&A slide. Now on the G&A, our plan has been to reduce cost across the year and future into next year as well. The larger tickets in Q2 are salaries, fees and related costs decreased in Q1 and in Q2 by $300,000 a quarter compared to what we were running in the second half of 2024. And Q1 and Q2 also had lower professional fees for legal, audit, consulting services, and they're $300,000 per quarter lower than Q4 of last year. So the costs are -- and these costs are primarily for the public reporting requirements, financing efforts, costs stemming from various trailing legal matters, but we expect these costs to continue to drop as the year progresses. So let's move on to the balance sheet, please. I'm not going to spend a lot of time here, but I do want to mention that the company has made and is continuing to make improvements to the balance sheet. We'll discuss those type items primarily in the debt and equity components on the next slide. So let's just go ahead and go to the debt slide. Do note that our senior debt continues to be paid down. It was originally at $28 million, now it's around $21 million. Big thing we have completed our efforts to exchange all the former pre- acquisition, short-term private loans and warrants to now the long-term convertible notes. Warrant liability is gone from the balance sheet. The overall combined liability of those started at $9.8 million, and it has now been reduced by over $4 million and it's about $5.6 million. Now let's go to the equity slide. There's nothing really new here from what I've shown before. The preferred stock will clean up when we close. But the warrants have dropped by $4 million, and that came from what we discussed on the debt slide. I will say in the equity section, I've had several questions about the S-1, and most of these are long-term possible versus issued shares. Let me just talk about -- a little bit about what's issued. It's South Justis acquisition back in June. There were 2 million shares. And all those were based on market, were up to $1 per share. So it was a good deal. And the overall price of South Justis, as we've talked in the past, was a very good deal. The only other issued shares were contract fees, and that was only $100,000 and that was between, again, a market- based issuance and $1. So again, good pricing. All the rest of it, you can call it shelf-type shares. Now forgive my slang, these are not issued. They come in two groups. The convertible note, these are the same as we've been discussing on the debt slide. There's nothing new here. Whatever we put in the S-1 is really a reserve to have if needed. Some will be used, but the number over the next few months is still unknown, and the amount is unknown. The other shelf-type shares of ELOC and this is, again, nothing new. It's been in place since October of 2022. And we've discussed this on every call. Currently, not using it. Over the past year plus, we've only used a small percentage of daily volume. We mentioned that on every call. So if we use it going forward, it's the same thing. It will only be a small percent. We're not envisioning using a whole lot, but again, this is essentially shelf shares and they're for need, and it just goes with the contract. So let's go on to the next slide, which is a future-looking slide, which plays basically what Dante has already covered and our press releases have kept you informed. So I'll just do a quick wrap up. Dante has already noted, we're -- it's all contingent on wrapping up the definitive docs. We expect to fund between $40 million and $50 million and via one or more volumetric funding instruments. They're not neither. They're not designed by debt or equity. So the funds first go to settle the seller agreement, as Dante noted, where we pay $20.5 million in return to get the 10% ORRI back the $15 million note plus accrued interest in the $5 million range and the preferred shares to clean up the equity section. All the funds from there will go towards paying off our senior debt with FIBT. All in all, as Dante mentioned, the monthly debt amortization of $700,000 is replaced with a much smaller ORRI type payment, volumetric payment. This is a big boost to our cash flow. So with that, I want to move on to Jesse to review operations. So please advance to Jesse's slide.